Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core - PubMed (original) (raw)
. 2006 Jan 27;281(4):2373-9.
doi: 10.1074/jbc.M510840200. Epub 2005 Nov 28.
Affiliations
- PMID: 16314415
- DOI: 10.1074/jbc.M510840200
Free article
Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core
Olga V Bocharova et al. J Biol Chem. 2006.
Free article
Abstract
Amyloids are highly ordered, rigid beta-sheet-rich structures that appear to have minimal dynamic flexibility in individual polypeptide chains. Here, we demonstrate that substantial conformational rearrangements occur within mature amyloid fibrils produced from full-length mammalian prion protein. The rearrangement results in a substantial extension of a proteinase K-resistant core and is accompanied by an increase in the beta-sheet-rich conformation. The conformational rearrangement was induced in the presence of low concentrations of Triton X-100 either by brief exposure to 80 degrees C or, with less efficacy, by prolonged incubation at 37 degrees C at pH 7.5 and is referred to here as "annealing." Upon annealing, amyloid fibrils acquired a proteinase K-resistant core identical to that found in bovine spongiform encephalopathy-specific scrapie-associated prion protein. Annealing was also observed when amyloid fibrils were exposed to high temperatures in the absence of detergent but in the presence of brain homogenate. These findings suggest that the amyloid fibrils exist in two conformationally distinct states that are separated by a high energy barrier and that yet unknown cellular cofactors may facilitate transition of the fibrils into thermodynamically more stable state. Our studies provide new insight into the complex behavior of prion polymerization and highlight the annealing process, a previously unknown step in the evolution of amyloid structures.
Similar articles
- Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils.
Ladner-Keay CL, Griffith BJ, Wishart DS. Ladner-Keay CL, et al. PLoS One. 2014 Jun 3;9(6):e98753. doi: 10.1371/journal.pone.0098753. eCollection 2014. PLoS One. 2014. PMID: 24892647 Free PMC article. - Two amyloid States of the prion protein display significantly different folding patterns.
Ostapchenko VG, Sawaya MR, Makarava N, Savtchenko R, Nilsson KP, Eisenberg D, Baskakov IV. Ostapchenko VG, et al. J Mol Biol. 2010 Jul 23;400(4):908-21. doi: 10.1016/j.jmb.2010.05.051. Epub 2010 May 27. J Mol Biol. 2010. PMID: 20553730 Free PMC article. - Pathway complexity of prion protein assembly into amyloid.
Baskakov IV, Legname G, Baldwin MA, Prusiner SB, Cohen FE. Baskakov IV, et al. J Biol Chem. 2002 Jun 14;277(24):21140-8. doi: 10.1074/jbc.M111402200. Epub 2002 Mar 23. J Biol Chem. 2002. PMID: 11912192 - Proteinase K resistant cores of prions and amyloids.
Kushnirov VV, Dergalev AA, Alexandrov AI. Kushnirov VV, et al. Prion. 2020 Dec;14(1):11-19. doi: 10.1080/19336896.2019.1704612. Prion. 2020. PMID: 31876447 Free PMC article. Review. - Is the prion structure solved?
Liberski PP, Bratosiewicz-Zapart J. Liberski PP, et al. Arch Immunol Ther Exp (Warsz). 1997;45(2-3):121-40. Arch Immunol Ther Exp (Warsz). 1997. PMID: 9597078 Review.
Cited by
- The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance.
Tycko R, Savtchenko R, Ostapchenko VG, Makarava N, Baskakov IV. Tycko R, et al. Biochemistry. 2010 Nov 9;49(44):9488-97. doi: 10.1021/bi1013134. Biochemistry. 2010. PMID: 20925423 Free PMC article. - The expanding universe of prion diseases.
Watts JC, Balachandran A, Westaway D. Watts JC, et al. PLoS Pathog. 2006 Mar;2(3):e26. doi: 10.1371/journal.ppat.0020026. PLoS Pathog. 2006. PMID: 16609731 Free PMC article. Review. - Conserved properties of human and bovine prion strains on transmission to guinea pigs.
Safar JG, Giles K, Lessard P, Letessier F, Patel S, Serban A, Dearmond SJ, Prusiner SB. Safar JG, et al. Lab Invest. 2011 Sep;91(9):1326-36. doi: 10.1038/labinvest.2011.89. Epub 2011 Jul 4. Lab Invest. 2011. PMID: 21727894 Free PMC article. - Two alternative pathways for generating transmissible prion disease de novo.
Makarava N, Savtchenko R, Baskakov IV. Makarava N, et al. Acta Neuropathol Commun. 2015 Nov 10;3:69. doi: 10.1186/s40478-015-0248-5. Acta Neuropathol Commun. 2015. PMID: 26556038 Free PMC article. - Purification and fibrillation of full-length recombinant PrP.
Makarava N, Baskakov IV. Makarava N, et al. Methods Mol Biol. 2012;849:33-52. doi: 10.1007/978-1-61779-551-0_4. Methods Mol Biol. 2012. PMID: 22528082 Free PMC article.